Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mouse lymphoma thymidine kinase gene mutation assay: meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment.
Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Clay P, Doppalapudi R, Fellows M, Gollapudi B, Hou S, Jenkinson P, Muster W, Pant K, Kidd DA, Lorge E, Lloyd M, Myhr B, O'Donovan M, Riach C, Stankowski LF Jr, Thakur AK, Van Goethem F; Mouse Lymphoma Assay Workgroup, IWGT. Moore MM, et al. Among authors: clay p. Mutat Res. 2007 Feb 3;627(1):36-40. doi: 10.1016/j.mrgentox.2006.08.013. Epub 2006 Dec 6. Mutat Res. 2007. PMID: 17157054
Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
Ashby J, Tinwell H, Callander RD, Kimber I, Clay P, Galloway SM, Hill RB, Greenwood SK, Gaulden ME, Ferguson MJ, Vogel E, Nivard M, Parry JM, Williamson J. Ashby J, et al. Among authors: clay p. Mutat Res. 1997 Dec 12;396(1-2):45-64. doi: 10.1016/s0027-5107(97)00174-7. Mutat Res. 1997. PMID: 9434859
The key role of specific DSM-5 diagnostic criteria in the early development of alcohol use disorder: Findings from the RADAR prospective cohort study.
Slade T, O'Dean SM, Chung T, Mewton L, McCambridge J, Clare P, Bruno R, Yuen WS, Tibbetts J, Clay P, Henderson A, McBride N, Mattick R, Boland V, Hutchinson D, Upton E, Isik A, Johnson P, Kypri K. Slade T, et al. Among authors: clay p. Alcohol Clin Exp Res (Hoboken). 2024 Jul;48(7):1395-1404. doi: 10.1111/acer.15379. Epub 2024 Jun 24. Alcohol Clin Exp Res (Hoboken). 2024. PMID: 38923856
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
Orkin C, Molina JM, Cahn P, Lombaard J, Supparatpinyo K, Kumar S, Campbell H, Wan H, Teal V, Jin Xu Z, Asante-Appiah E, Sklar P, Teppler H, Lahoulou R; DRIVE-FORWARD and DRIVE-AHEAD collaborators. Orkin C, et al. Lancet HIV. 2024 Feb;11(2):e75-e85. doi: 10.1016/S2352-3018(23)00258-8. Epub 2023 Dec 20. Lancet HIV. 2024. PMID: 38141637 Clinical Trial.
133 results